HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome

稿件作者:廖循
通讯作者:
刊物名称:Neurobiology of Disease
发表年份:2019
卷:
期:132
页码:104585-1 - 104585-14
影响因子:5.23
文章摘要:
全文链接: